| 查看: 575 | 回复: 7 | ||
| 【奖励】 本帖被评价4次，作者ludasheng-1增加金币 3.5 个 | ||
| 当前主题已经存档。 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
[资源]
Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)
|
||
 Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development) By Sayed S. Daoud Publisher: Humana Press Number Of Pages: 300 Publication Date: 2007-11-13 ISBN-10 / ASIN: 1588298582 ISBN-13 / EAN: 9781588298584 Binding: Hardcover This book provides the reader with broad perspectives and breadth of knowledge on current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its application in daily practice. The book is divided into 4 parts. The first part begins with the current technologies used in proteomics that allow for protein profiling and for the identification of druggable targets in human samples. Mass spectrometry based protein characterization and protein microarrays hold great promise of predicting response to specific drugs in cancer therapy. The second part deals with the use proteomics in cell signaling. At the present, the pharmaceutical and biotechnology industries have many potentially useful small molecule inhibitors of many pathways important in cancer that have yet to be taken to clinical trials. Understanding protein-protein interaction and posttranslational modifications through proteomics will likely make it much more feasible to do effective clinical trials of these small molecules alone and in combinations to overcome drug resistance and improve patient care. The third part of the book moves from signaling to actual clinical applications of proteomics in cancer therapy. Case studies in may tumor types are provided to show the feasibility of generating the critical information needed to individualization of therapy in cancer patients. The final part of the book provides in depth information on annotating the human proteome and the role of Food and Drug Administration (FDA) in regulating the use of proteomics in cancer therapy. To functionally annotate the human proteome, the Swiss Institute for Bioinformatics (SIB) and the European Bioinformatics Institute (EBI) initiated a major effort to distribute to the scientific community highly integrated information on human protein sequences. This initiative, which is called the Human Proteomics Initiative (HPI) aims to provide for each known human protein a wealth of information that include the description of its function, domain and protein family classification, subcellular location, posttranslational modifications, variants and similarities to other proteins. Integration of bioinformatics into clinical application of proteomics in cancer therapy is outlined as well as regulations and policy of commercial application of proteomics in patient care. Link: http://rapidshare.com/files/79603386/asd_Cancer_Proteomics.rar http://www.megaupload.com/?d=TSQS7G6L http://w15.easy-share.com/13439551.html http://depositfiles.com/files/2867982 http://rapidshare.com/files/7968 ... .bioXplorer.com.rar [search]Cancer Proteomics[/search] |
回复此楼» 猜你喜欢
一志愿 江南大学 085602 化工专硕 338分求调剂
已经有8人回复
-
304求调剂（085602，过四级，一志愿985）
已经有15人回复
-
工科求调剂
已经有15人回复
-
求调剂
已经有5人回复
-
277求调剂
已经有3人回复
-
化学0703-一志愿211-338分求调剂
已经有4人回复
-
266分，一志愿电气工程，本科材料，求材料专业调剂
已经有8人回复
-
材料调剂
已经有3人回复
-
22408 总分320，一篇论文二作，两个国三，求调剂
已经有4人回复
-
313求调剂
已经有5人回复
3楼2007-12-30 09:07:34
2楼2007-12-30 05:54:04
4楼2007-12-30 09:30:31
5楼2008-02-21 21:28:54
